How Bone and Cartilage Conduction Actually Work

Bone conduction audio technology transmits sound by vibrating the bones of the skull or cartilage of the ear rather than directing acoustic pressure waves through the air canal — enabling audio delivery while keeping the ear canal fully open. This physical distinction from conventional headphone design is what makes bone conduction relevant to hearing health, industrial safety, and mixed-reality applications where situational awareness cannot be sacrificed.

Within the patent dataset analysed, three physically distinct coupling mechanisms appear: coupling vibrations to the mastoid bone or jaw (classical bone conduction); vibrating the auricle (outer ear cartilage) to generate acoustic pressure waves at the ear canal entrance — a technique termed cartilage conduction; and positioning off-ear speakers adjacent to the ear in head-mounted displays. All three approaches share the same design objective: delivering audio without occluding the ear canal.

The most technically detailed cartilage conduction record in the dataset is Meta Platforms Technologies’ 2020 KR filing, which describes a transducer assembly attached to the back of the auricle with a controller that dynamically adjusts its frequency response model based on real-time acoustic sensor feedback positioned at the ear canal entrance. This closed-loop correction distinguishes it from earlier, fixed-response bone conduction transducers documented in the literature by organisations such as WHO in their global hearing loss frameworks.

A second distinct approach documented in the dataset is a hybrid bone conduction woofer system (Kim Bong-seok, 2023, KR) in which low-frequency vibrational stimuli are transmitted to cervical acupuncture points via a neck-worn bone conduction woofer, while wired or wireless earphones handle high- and mid-frequency audio reproduction. This positions bone conduction not merely as an audio delivery channel but as a therapeutic stimulus modality — a framing that opens regulatory and reimbursement pathways distinct from standard consumer audio.

From Foundational Patents to 2026 Frontier Activity

The patent dataset spans from 2003 to early 2026, allowing a maturity trajectory to be mapped across four recognisable periods. Each period reflects a shift in the primary technical challenge being addressed — from basic signal processing and noise reduction, through form-factor diversification, to the AI-mediated personalisation and XR integration that characterise the current frontier.

The foundational period (pre-2015) produced a small cluster of records addressing audio conferencing hardware, noise reduction circuitry, and hearing profiling fundamentals. Ichiha Medical Inc.’s 2016 JP filing on consumer audiometric self-testing using standard PC hardware is a representative example — an early precursor to the personalised hearing management systems now entering the market.

The expansion period (2016–2020) saw broadening of audio wearable concepts. Meta Platforms Technologies’ cartilage conduction eyewear system (2020, KR) and ambient sound wireless earphone designs (Loonsteen Benoit, 2020, FR) both indicate commercial interest in open-ear audio form factors taking hold across multiple geographies and assignee types.

The convergence period (2021–2023) produced the densest cluster of filings in the dataset: adaptive ANC, wearable fit calibration, and hybrid therapeutic/audio devices all appear. Apple Inc.’s multiple filings on headphone fit adjustment and acoustic coupling quality measurement signal major platform-level investment in this problem space — a signal that ITU standards bodies and audio engineering organisations have also begun to formalise in accessibility guidance.

“Apple Inc.’s multi-year, multi-jurisdiction coverage of wearable audio fit calibration suggests that acoustic coupling quality measurement will become a standard platform feature — not a differentiator.”

The most recent filings (2024–2026) show renewed focus on HMD-integrated off-ear audio and AI-driven hearing aid management. Tongji Hospital’s 2026 JP filing on a comprehensive hearing test and fitting management system, and Valve Corporation’s dual 2025 filings on HMD fan noise active noise reduction, represent the frontier activity captured in this dataset.

Four Technology Clusters Driving the Patent Landscape

The patent records in this dataset organise naturally into four technology clusters, each addressing a distinct engineering challenge within the broader open-ear audio space. Understanding these clusters is essential for R&D teams assessing freedom-to-operate or identifying white space.

Cluster 1: Cartilage and Bone Vibration Transducers

This cluster couples mechanical vibration directly to the auricular or skeletal structure, bypassing the ear canal entirely. The defining technical feature in the most advanced records is dynamic frequency response correction: a sensor positioned at the ear canal entrance detects acoustic pressure in real time, and a controller adjusts the transducer’s frequency response model accordingly. Meta Platforms Technologies’ 2020 KR filing is the primary example. A second record — Kim Bong-seok’s 2023 KR filing — extends bone conduction to a neck-worn device that transmits vibrational stimuli to cervical acupuncture points while conventional earphones handle high- and mid-frequency reproduction.

Cluster 2: Wearable Fit Calibration and Adaptive Acoustic Coupling

This cluster focuses on measuring the quality of acoustic coupling between a wearable audio device and the user’s ear anatomy, then automatically prompting adjustment or modifying equalisation parameters. Apple Inc. holds three filings in this cluster across KR (2021), JP (2023), and JP (2025) jurisdictions. The core technique involves outputting a calibration tone and using paired internal and external microphone signals to assess device fit and prompt user adjustment. Huawei Technologies’ 2025 KR filing advances this further by pre-storing N1 filtering parameter groups corresponding to N1 distinct ear canal leakage states, selecting the optimal group based on current wearing geometry to improve ANC performance.

Cluster 3: Off-Ear and Extra-Aural Speakers in Head-Mounted Displays

Head-mounted displays increasingly incorporate off-ear speakers positioned near — but not inside — the ear canal. This is functionally adjacent to bone conduction in that it preserves situational awareness while delivering audio. The primary technical challenge being addressed in this cluster is active noise reduction of device-generated noise, specifically cooling fan noise. Valve Corporation’s dual 2025 filings (KR and JP) describe a system that receives fan noise data, applies a signal model to determine audio parameter values, and outputs anti-noise through off-ear speakers to cancel fan noise at the user’s ear location. According to IEEE signal processing standards, this type of feedforward ANC architecture is well-suited to predictable, periodic noise sources such as cooling fans.

Cluster 4: Hearing Health and Therapeutic Audio Delivery

Bone conduction and vibrational stimulation are applied in hearing aid fitting, tinnitus management, and therapeutic low-frequency stimulation in this cluster. Han Chang-yong’s 2020 KR tinnitus self-treatment filing describes 3D-scanned and printed custom ear-level devices with smartphone application integration, frequency-specific acoustic correction, and brainwave-controlled therapeutic sounds targeting the cerebral auditory region. Sharp Corporation’s 2025 JP filing enables remote hearing aid fitting via two-terminal authentication, eliminating the need for store visits. Tongji Hospital’s 2026 JP filing describes a centralised fitting database with AI-suggested answers pushed to audiologists based on patient daily-use feedback — closing the loop between real-world experience and clinical fitting adjustment.

Where Innovation Is Concentrated: Assignees and Geographies

Korea (KR) is the dominant jurisdiction by filing count within this dataset, accounting for the majority of retrieved records. Japan (JP) is the second most represented jurisdiction. US-originating inventions appear through Korean and Japanese national phase entries from Apple Inc., Meta Platforms Technologies, Valve Corporation, and Magic Leap. China (CN) appears in one relevant Huawei filing on ANC. France (FR) and Spain (ES) are each represented by single records.

Innovation is not uniformly distributed across assignees. Apple Inc. holds the most filings in the dataset, with systematic multi-jurisdiction coverage of wearable fit calibration across KR (2021), JP (2023), and JP (2025). Valve Corporation’s two 2025 filings (KR and JP) on HMD off-ear speaker ANR represent a concentrated dual-jurisdiction strategy. Meta Platforms Technologies holds the only explicitly labeled cartilage conduction patent for eyewear in the dataset. Huawei Technologies contributes one technically significant ANC filing. In hearing health, Sharp Corporation (JP) and Tongji Hospital (JP) represent the clinical and device-maker perspectives respectively.

The geographic concentration in KR and JP filings reflects both the importance of these markets for consumer electronics and hearing health device commercialisation, and the filing strategies of US platform companies (Apple, Meta, Valve) who enter these jurisdictions through national phase. This pattern is consistent with filing behaviour documented by WIPO in its annual global IP statistics, where KR and JP consistently rank among the top five patent offices by application volume for audio and wearable technology classifications.

Five Emerging Directions Shaping the Next Wave

The most recent filings (2024–2026) within this dataset point to five forward-looking directions that R&D and IP teams should monitor. These are not speculative extrapolations — they are directly evidenced by the patent records described in the source dataset.

1. AI-Driven Hearing Personalisation at the Clinical Interface. Tongji Hospital’s 2026 JP filing describes a database-driven fitting management system that uses patient daily-use feedback to train suggested answers for audiologists. This architecture — continuous AI-mediated optimisation between clinic visits — is directly applicable to remote bone conduction hearing device fitting and represents a shift from periodic calibration to always-on personalisation.

2. Leakage-Aware Adaptive ANC as a Foundation for Open-Ear Audio. Huawei’s 2025 KR filing on N1-state leakage-parameterised ANC filtering addresses the core acoustic engineering challenge of open-ear and bone conduction wearables: maintaining noise cancellation performance when the device does not form a hermetic seal with the ear canal. As bone conduction devices are inherently “leaky,” this parameterisation strategy is directly applicable and likely to become a mandatory capability for premium-tier products. The ITU has noted the growing importance of adaptive signal processing in assistive listening device standards.

3. HMD Off-Ear Speaker Systems with Active Noise Control. Valve Corporation’s dual 2025 filings (KR, JP) on extra-aural speaker ANR in VR headsets signal that the XR platform is converging toward open-ear audio architectures. As HMD form factors slim toward lightweight AR glasses, the distinction between “off-ear speaker” and “bone/cartilage conduction” narrows — creating both IP overlap risk and white space opportunity.

4. Remote and Over-the-Air Device Fitting. Sharp Corporation’s 2025 JP filing on remote hearing aid fitting via authenticated two-terminal architecture, and the Tongji Hospital AI fitting management system, together signal that over-the-air personalisation — including gain profile adjustment, frequency response tuning, and leakage compensation — is moving from optional feature to expected standard for any advanced audio wearable.

5. Therapeutic Vibrational Audio Integration. The bone conduction woofer neck-wear system (Kim Bong-seok, 2023, KR) integrating acupuncture-point stimulation with audio reproduction, and the tinnitus brainwave-controlled therapeutic sound system (Han Chang-yong, 2020, KR), suggest a growing wellness and therapeutic sub-market in which bone conduction is positioned as a primary therapeutic modality rather than a substitute for conventional hearing.

Strategic Implications for IP and R&D Teams

The patent signals in this dataset translate into five concrete strategic implications for organisations active in or entering the bone conduction audio space. Each implication is grounded directly in the filing evidence described above.

IP White Space in Cartilage Conduction. Within this dataset, only Meta Platforms Technologies holds an explicitly labeled cartilage conduction patent for eyewear. Given the rapid growth of smart glasses form factors — a trend tracked by patent offices including the EPO in its emerging technology reports — this represents a relatively uncrowded sub-domain where new entrants could build defensible positions around transducer mounting geometry, dynamic frequency response correction, and multi-point auricle coupling.

Leakage State Modelling is a Critical Enabler. Huawei’s 2025 KR filing on leakage-state-parameterised ANC establishes that managing acoustic seal variability is now a first-class engineering problem. R&D teams developing bone conduction or open-ear devices should prioritise signal processing IP around leakage detection and compensation, as this will likely become a mandatory capability for any premium-tier product.

Apple’s Fit Calibration Architecture Sets a Platform Expectation. Apple’s multi-year, multi-jurisdiction coverage of wearable audio fit calibration (KR 2021, JP 2023, JP 2025) suggests that acoustic coupling quality measurement will become a standard platform feature. Competitors and component suppliers should assess freedom-to-operate around calibration tone generation, microphone-based fit detection, and the user interface flow for user-prompted adjustment.

XR and Bone Conduction Roadmaps are Converging. The shift of VR/AR headsets toward off-ear and open-ear audio — evidenced by both Valve Corporation and Meta Platforms Technologies filings — means that bone and cartilage conduction R&D organisations should actively monitor XR platform IP. Form factor convergence toward lightweight AR glasses with cartilage conduction audio is technically plausible and commercially incentivised.

Hearing Health Applications Offer Regulatory and Reimbursement Pathways. The clustering of audiometric, tinnitus, and hearing aid fitting patents filed by both clinical institutions (Tongji Hospital) and device makers (Sharp Corporation) confirms that hearing health is a commercially validated entry point for bone conduction technology, with clearer regulatory pathways and reimbursement structures than purely consumer applications.

“Within this dataset, only one assignee — Meta Platforms Technologies — holds an explicitly labeled cartilage conduction patent for eyewear. This is a relatively uncrowded sub-domain where new entrants could build defensible IP positions.”